Evidence map›Paper›PMID 26512010›Full record

ReviewApplied microbiology and biotechnology2016

Biotechnological production and application of the antibiotic pimaricin: biosynthesis and its regulation.

Jesús F Aparicio, Eva G Barreales, Tamara D Payero, Cláudia M Vicente, Antonio de Pedro, Javier Santos-Aberturas

Open access · hybridAbstract readReview
In one paragraph

Review in Applied microbiology and biotechnology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 115 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Catching the ElusiveBiotech (Basel (Switzerland)) · 2026
    Review
  5. Article
  6. Article
  7. Improved Natamycin Production inMicroorganisms · 2025
    Article
  8. Article
  9. Improving the production of natamycin inFood science and biotechnology · 2024
    Article
  10. Article
  11. Article
  12. Natamycin Has an Inhibitory Effect onMolecules (Basel, Switzerland) · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Jesús F AparicioArea of Microbiology, Faculty of Biology, Universidad de León, 24071, León, Spain. jesus.aparicio@unileon.es.ORCID http://orcid.org/0000-0003-4242-4701
Eva G BarrealesArea of Microbiology, Faculty of Biology, Universidad de León, 24071, León, Spain.
Tamara D PayeroArea of Microbiology, Faculty of Biology, Universidad de León, 24071, León, Spain.
Cláudia M VicenteDynamique des Génomes et Adaptation Microbienne, UMR 1128, INRA, Université de Lorraine, 54506, Vandoeuvre-lès-Nancy, France.
Antonio de PedroArea of Microbiology, Faculty of Biology, Universidad de León, 24071, León, Spain.
Javier Santos-AberturasDepartment of Molecular Microbiology, John Innes Centre, Norwich Research Park, Norwich, NR4 7UH, UK.
Universidad de León · ESDynamique des Génomes et Adaptation Microbienne · FRJohn Innes Centre · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pimaricin (natamycin) is a small polyene macrolide antibiotic used worldwide. This efficient antimycotic and antiprotozoal agent, produced by several soil bacterial species of the genus Streptomyces, has found application in human therapy, in the food and beverage industries and as pesticide. It displays a broad spectrum of activity, targeting ergosterol but bearing a particular mode of action different to other polyene macrolides. The biosynthesis of this only antifungal agent with a GRAS status has been thoroughly studied, which has permitted the manipulation of producers to engineer the biosynthetic gene clusters in order to generate several analogues. Regulation of its production has been largely unveiled, constituting a model for other polyenes and setting the leads for optimizing the production of these valuable compounds. This review describes and discusses the molecular genetics, uses, mode of action, analogue generation, regulation and strategies for increasing pimaricin production yields.

Indexed as

Gene Expression Regulation, BacterialAntifungal AgentsBiosynthetic PathwaysBiotechnologyHumansNatamycinStreptomycesAntifungal AgentsNatamycinAntifungal agentCheeseGene regulationKeratitisMetabolic engineeringPolyene macrolidePreservative E-235Streptomyces

Identifiers

PMID26512010
PMCPMC4700089
OpenAlexW1819652514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.